Back    Zoom +    Zoom -
<Results>SINOPHARM 1Q NP Falls 3% YoY to RMB1.41B
Recommend
3
Positive
5
Negative
3
SINOPHARM (01099.HK) has announced its results for 1Q ended March 2026 prepared in accordance with China's GAAP.

The company's operating revenue dropped by 0.6% YoY to RMB140.77 billion, while net profit fell by 3% YoY to RMB1.41 billion, with EPS of RMB0.45.

Related NewsSinopharm Group (01099.HK) Subsidiary Sinopharm Consistent (000028.SZ) 1Q Net Profit RMB287M, Down 12.4% YoY


Auto-translated by AI

AASTOCKS Financial News